These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25840605)

  • 1. Designing drugs that combat kidney damage.
    Ramos AM; González-Guerrero C; Sanz A; Sanchez-Niño MD; Rodríguez-Osorio L; Martín-Cleary C; Fernández-Fernández B; Ruiz-Ortega M; Ortiz A
    Expert Opin Drug Discov; 2015 May; 10(5):541-56. PubMed ID: 25840605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization strategies for the development of new drugs that treat chronic kidney disease.
    Ramos AM; Fernández-Fernández B; Pérez-Gómez MV; Carriazo Julio SM; Sanchez-Niño MD; Sanz A; Ruiz-Ortega M; Ortiz A
    Expert Opin Drug Discov; 2020 Jan; 15(1):101-115. PubMed ID: 31736379
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of acute renal failure on drug metabolism.
    Philips BJ; Lane K; Dixon J; Macphee I
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):11-23. PubMed ID: 24074057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
    Gao L; Zhong X; Jin J; Li J; Meng XM
    Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New renal drug development to face chronic renal disease.
    Moll S; Meier M; Formentini I; Pomposiello S; Prunotto M
    Expert Opin Drug Discov; 2014 Dec; 9(12):1471-85. PubMed ID: 25195802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury: gateway to chronic kidney disease.
    Heung M; Chawla LS
    Nephron Clin Pract; 2014; 127(1-4):30-4. PubMed ID: 25343817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of animal models of acute kidney injury and its impact on drug discovery.
    Sanz AB; Sanchez-Niño MD; Martín-Cleary C; Ortiz A; Ramos AM
    Expert Opin Drug Discov; 2013 Jul; 8(7):879-95. PubMed ID: 23627598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.
    Szeto HH
    J Am Soc Nephrol; 2017 Oct; 28(10):2856-2865. PubMed ID: 28778860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent early clinical drug development for acute kidney injury.
    Gallagher KM; O'neill S; Harrison EM; Ross JA; Wigmore SJ; Hughes J
    Expert Opin Investig Drugs; 2017 Feb; 26(2):141-154. PubMed ID: 27997816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: A Candidate Drug for Renal Diseases.
    Corremans R; Vervaet BA; D'Haese PC; Neven E; Verhulst A
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional relationships between acute kidney injury and chronic kidney disease.
    Pannu N
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):351-6. PubMed ID: 23508059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and autophagy: crucial modulators of kidney injury.
    Sureshbabu A; Ryter SW; Choi ME
    Redox Biol; 2015; 4():208-14. PubMed ID: 25613291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Cell-Targeted Drug Delivery Strategy for Acute Kidney Injury and Chronic Kidney Disease: A Mini-Review.
    Liu D; Du Y; Jin FY; Xu XL; Du YZ
    Mol Pharm; 2021 Sep; 18(9):3206-3222. PubMed ID: 34337953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney Disease: A Case for Phenotypic Drug Discovery in Acute Kidney Injury.
    Hukriede N; Vogt A; de Caestecker M
    Nephron; 2017; 137(4):268-272. PubMed ID: 28614822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury and chronic kidney disease: it's a two-way street.
    Kline J; Rachoin JS
    Ren Fail; 2013; 35(4):452-5. PubMed ID: 23409917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target.
    Lin TY; Hsu YH
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
    Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.